First-in-human study of ZGGS15, a dual-specific antibody targeting LAG-3 and TIGIT, as monotherapy in patients with advanced solid tumors.

Authors: Ji Zhu, Zhen Wang, Xiaoli Chai, Lihua Wu, Song Qu, Linlin Liu, Yanyan Liu, Yan Sun

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.2641

Source: Full article

---

Abstract

2641